Cost‐effectiveness analysis of individual‐level obesity treatment in paediatrics: A scoping review

Abstract

SummaryObjectivesThis scoping review informs a health economics perspective on the treatment of paediatric obesity. The results detail recently published research findings on the cost‐effectiveness of paediatric obesity treatments and identify key characteristics of cost‐effective interventions.MethodsA structured search was applied to six databases with no data restriction through March 2023: Medline, Embase, Cochrane CENTRAL, CINAHL, and PsycINFO. Studies that included a cost analysis of an individual level, weight management intervention (behavioural, pharmacotherapy, and surgical) in youth, with obesity, ages 2 to 21 years were eligible for inclusion.ResultsOf the 4371 records identified in the initial search, 353 underwent full‐text review, 39 studies met the pre‐specified inclusion criteria. The majority were published after 2010 (n = 36/39, 92%) and applied to high‐income countries (n = 39/39, 100%). Thirty‐five of the studies assessed the cost‐effectiveness of lifestyle interventions (90%), and four studies assessed surgical outcomes (10%). No pharmacotherapy studies met eligibility criteria. Although the outcome measures differed across the studies, all four surgical interventions were reported to be cost‐effective. Thirty of the 35 (85%) lifestyle modification studies were reported to be cost‐effective compared to the study comparator examined.ConclusionsThere is a small amount of evidence that individual‐level paediatric obesity treatment interventions are cost‐effective and, in some cases cost‐saving, with most of this work conducted on behavioural interventions. The economic evaluation of paediatric obesity interventions poses various methodologic challenges, which should be addressed in future research to fully use the potential of economic evaluation as an aid to decision‐making.